ABSTRACT Effects of the anti-T-cell monoclonal antibodies OKT3, OKT5, and OKT8 on T-cell surface properties and cell functions were evaluated. Incubation of mononuclear cells isolated from peripheral blood for 48 hr with each monoclonal antibody in the absence of complement resulted in modulation of their respective surface antigens; i.e., the number ofcells detected by immunofluorescence as positive for the T3, T5, and T8 surface antigens was reduced. T3, T5, and T8 antigens modulated independently. A radiolabeled second antibody technique confirmed modulation by OKT3 and OKT8 and indicated that T-cell differentiation antigens can regenerate in culture. Incubation of mononuclear cells with OKT3 increased the number of sheep erythrocyte-binding lymphocytes (E+-rosetting cells) and markedly increased the number ofavidly E+-rosetting cells. Incubation with OKT8 reduced the number ofE+-and of avidly E+-rosetting cells. OKT3 induced both mitogenic reactivity and suppressor cell activity; cells modulated by OKT8 exhibited reduced mitogenic reactivity and reduced suppressor cell function. The decreases in total T cells, in avid T cells, in suppressor cell number, and in suppressor cell function that follow modulation by OKT8 mimic changes observed in multiple sclerosis patients.
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T-cell subset counts in blood and T-cell subset functions as detected by in vitro assays are aberrant in several diseases suspected to be autoimmune processes. During attacks ofmultiple sclerosis (MS), circulating T cells, whether defined as cells that form rosettes with sheep erythrocytes (E+-rosetting cells) or as cells that bear the T3 surface differentiation antigen, are decreased in number (1) (2) (3) (4) (5) (6) . During both stable and active phases of MS, the number ofavid or early E+-rosetting cells is likewise reduced (7) (8) (9) . The T suppressor/cytotoxic (TS) cell subset, de- tected by presence on the cell surface of the differentiation antigens T5 and T8, is decreased during attacks of MS, as is the suppressor cell containing the TG cell subset recognized by the presence of Fc receptors for IgG (5, 6, 10) . Finally, suppressor cell function measured in vitro is defective during active MS (11) (12) (13) .
Mechanisms to explain this array ofchanges in T-cell number and function in MS include destruction ofdiscrete T-cell subsets and modulation of T-cell surface antigens. In MS, antibodies that induce complement-dependent lympholysis in vitro are sometimes found but no correlation with disease activity has been shown (14) (15) (16) . Whether such antibodies lyse Ts cells selectively, as has been shown to be the case in systemic lupus erythematosus (17, 18) , is not known. In vitro lympholysis, when mediated by disease-associated antibodies, is greater at room than at body temperature. As with disease-associated antibodies (17) (18) (19) , monoclonal antibody (mAb) to Ts cells (e.g., OKT8 ) can induce complement mediated lysis of Ts cells in culture (20) .
Antibodies may, under certain circumstances, modulate cell surface antigens without lysing the cells (21) (22) (23) . This mechanism, which may be important in vivo, involves antibody interaction with cell surface antigen, redistribution of antigenantibody complexes (capping), and endo-or exocytosis. The process requires a metabolically active cell. Modulation of a Tcell subset-confined differentiation antigen could remove the very marker that permits detection of the subset. Thus, modulation might result in apparent underrepresentation of the number of cells in a given subset.
Interaction of antibody with cell surface antigens may also affect cell function. The mAb OKT3, which is a marker for the total T-cell population, induces profound mitogenic effects (24) whereas the Ts-specific mAbs OKT5 and OKT8 inhibit concanavalin A (Con A)-and phytohemagglutinin-induced mitogenic reactivity (25) . mAbs directed against Ts cells will also, in the absence of complement, inhibit cytolytic activity (25) (26) (27) .
We have evaluated the capacity of the anti-T-cell mAbs OKT3, OKT5, and OKT8 to modulate their respective surface differentiation antigens and have studied the effects of modulation on both cell membrane properties and cell function. (5 ,ug/ml for OKT8, 2.5 pug/ml for OKT3, and 10 ,ug/ ml for OKT5) and incubated for 30 min at,0C. After incubation, 10 ml of medium (RPMI/20% heat-inactivated fetal bovine serum containing gentamycin at 100 itg/100 ml) was added. Cells in. medium were then cultured for 48 hr at 37°C in humidified 5% C02/95% air. Cells treated as described above will be referred to as modulated cells. "Control culture" cells were similarly kept at 0°C for 30 min but without added mAb, suspended in 10. ml of medium, and cultured for 48 hr. I I-Labeled Goat Anti-Mouse IgG (GAM-IgG) Binding Assay. One hundred micrograms of IgG isolated from a goat antimouse serum (Nordic, El Toro, CA) by ammonium sulfate precipitation and DEAE chromatography was iodinated by the lactoperoxidase method of Marchalonis (28) . Free iodide was separated by Sephadex G-25 chromatography. The "2I-labeled GAM-IgG was diluted in HBSS/1% bovine serum albumin/ 10% goat serum containing a large excess of unlabeled iodide, so that a 25-1.l aliquot contained 20,000 cpm. MNCs, either freshly isolated, modulated, or from control cultures, were pelleted and incubated with mAb at 2.5 ug/ml as in the immu-T Rosette Determination. Total E+-rosetting cells and avid E -rosetting cells were enumerated as reported (7) except that macrophages were not removed from the MNC preparation.
METHODS
Assays of Lymphocyte Function. Mitogenesis and suppressor cell function induced by mAb or Con A. Our methods to determine mitogen response and suppressor cell function have been reported (11) . Samples of pelleted MNCs were incubated for 30 min with mAb as described for the modulation procedure, suspended at 106 cells per ml, and cultured in flasks (Falcon) for 96 hr. Other MNC samples were cultured with Con A at 3 ,ug/ml or in medium alone for 96 hr. Mitogenesis was determined by pulsing aliquots with [3H]thymidine for 5 hr.
Suppressor cell activity was assayed on the mAb-treated, Con A-stimulated, and control cultures described above. After 96 hr, cells from each culture were treated with mitomycin C (25 ,ug/ml) and washed, and 105 cells in 100-1ul aliquots from each sample were recultured with 105 fresh autologous or heterologous responder cells also in 100 ,ul ofmedium. The new culture medium contained Con A at a final concentration of 3 jig/ml. Seventy-two hours later, [3H]thymidine uptake from quadruplicate cultures was measured after a 5-hr pulse.
Percent suppression induced by mAb or Con A was calculated as The cells were again washed three times, the supernatant was aspirated, and the cell pellet was assayed in a gamma counter. Mitogenic capacity and suppressor cell activity ofmAb-modulated cells. To determine the Con A-induced mitogenic capacity of mAb-modulated or control culture cells, MNCs were suspended after their initial 48 hr of culture in fresh medium containing Con A (3 jig/ml) and cultured for a further 48 hr.
Cell aliquots taken from each culture flask were then pulsed for 5 hr with [3H]thymidine. 12 23 As shown in Table 3 , when modulated cells were washed repeatedly and then cultured for an additional 48 hr in antibodyfree medium, OKT3 and OKT8 specific binding of l"I-labeled GAM-IgG increased 2-to 20-fold, indicating that modulated antigens had been regenerated.
Effects of Anti-T-Cell Subset mAbs on T-Cell Function. Incubation with OKT3. OKT3 induced mitogenesis. After 96 hr in culture with OKT3, [3H]thymidine incorporation was 88,836 * 33,142 cpm (mean ± SEM for three individuals) vs. 70,404 * 24,595 (mean ± SEM) for cells from the same individuals incubated with Con A. OKT3 also induced suppressor cell activity as intense as that induced with Con A [41 ± 11% (n = 4) with OKT3 compared with 41 ± 7% (n = 7) with Con A].
Incubation uith OKT5 or OKT8. OKT5 and OKT8 did not induce cell proliferation after 96 hr as measured by [3H]thymidine incorporation [1,360 ± 477 cpm (n = 6) for OKT5 and 1,033 ± 498 cpm (n = 9) for OKT8 compared with 1,267 ± 716 (n = 10) for controls] and OKT8 did not induce suppressor cell activity [mean suppression -1 + 8% (n = 6)]. When OKT8-modulated MNCs were further cultured in fresh medium containing Con A, [3H]thymidine uptake at 48 hr [36,912 ± 7,482 cpm (n = 11)] was less than that ofcontrol culture MNCs (44,138 ± 7,482 cpm; P < 0.05, paired t test). Reduced [3H]thymidine uptake was found in 12 of 16 donors. When OKT8-modulated MNCs were cultured with Con A and the suppressor cell activity thus induced was assayed, the suppression observed was reduced significantly (29 ± 5%) from that seen with control culture cells handled in the same way (43 ± 6%; P < 0.02, paired t test; see Table 1 ). In a limited number of studies, no reduction in suppressor function was found to follow OKT5 modulation (Table 4) .
DISCUSSION
By using immunofluorescence techniques, we have found that modulation of T3, T5, and, to a lesser extent, T8 antigens occurs when cells are cultured with these mAbs. Modulation ofantigen by specific antibody has been observed in a wide variety of an- Our functional studies confirm the marked mitogenic properties of mAb OKT3 (24) . Data (25) . These workers found that direct addition of OKT8 to MNCs reduced response to Con A. The effect of OKT8 on functional suppressor activity shown here should be compared with their finding (25) that addition of OKTh to cytolytic cells generated in mixed lymphocyte reactions blocked cytolytic activity. Cytolytic and suppressor activity may be mediated by identical Tcell subsets (25) (26) (27) .
As an additional measure of modulation, a radiolabeled second antibody technique was used. This semiquantitative technique confirmed that OKT3 modulates T3 and that OKT8 modulates T8. By using the radiolabeled technique, we showed that the amount of T3 and T8 antigens present on cells rebounds in culture once the mAb has been removed from the medium. This finding establishes that, as reported in other systems (21, 22) , modulation is reversible.
Our observations on the effects of mAbs directed against Tcell differentiation antigens invite comparison with T-cell alterations observed in MS patients. In MS, response to T-cell mitogens is modestly reduced (33) . Suppressor cell function and suppressor cell number, as defined by OKT5 and OKT8 antibodies, are reduced when disease is active. Our data show that a mAb directed against T8 antigen reduces mitogenic reactivity, albeit modestly, and suppressor cell function as well. Antibodies directed against T5 and T8 can also lead to underestimation of suppressor cell number subset. When MNCs from MS patients are kept in culture for 48 hr, the number of T8-positive cells increases, a finding that supports the postulate that in vivo modulation may be occurring (unpublished results). Autoantibodies to lymphocytes, as determined both by immunofluorescence and complement-dependent cytolysis, have been shown to be increased in some MS patients (14) (15) (16) . Their role in the disease remains to be defined; possibly, they modulate surface antigens, including T8. We have presented evidence that mAb OKT8 crossreacts with oligodendroglial cells, the putative cell target in MS, and suggested that antibodies directed against antigens shared by oligodendroglial cells and by lymphoid cells may alter both cell types (34) .
